PHS
PFM Health Sciences Portfolio holdings
AUM
$1.15B
This Quarter Return
+16.19%
1 Year Return
+21.39%
3 Year Return
+130.75%
5 Year Return
+265.32%
10 Year Return
+1,236.5%
AUM
$2.01B
AUM Growth
+$2.01B
(+21%)
Cap. Flow
+$161M
Cap. Flow
% of AUM
8%
Top 10 Holdings %
Top 10 Hldgs %
42.09%
Holding
88
New
23
Increased
17
Reduced
15
Closed
3
Top Buys
| 1 |
Intuitive Surgical
ISRG
|
$34.6M |
| 2 |
Zimmer Biomet
ZBH
|
$24.8M |
| 3 |
DexCom
DXCM
|
$21.6M |
| 4 |
iShares Russell 2000 ETF
IWM
|
$20.8M |
| 5 |
West Pharmaceutical
WST
|
$20.3M |
Top Sells
| 1 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
$41.2M |
| 2 |
INBX
Inhibrx, Inc. Common Stock
INBX
|
$17.1M |
| 3 |
Day One Biopharmaceuticals
DAWN
|
$15.7M |
| 4 |
Roivant Sciences
ROIV
|
$13.6M |
| 5 |
Sana Biotechnology
SANA
|
$12.1M |
Sector Composition
| 1 | Healthcare | 95.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Eli Lilly
LLY
$657B
| $232M | 10.92% | 298,643 | – | – |
|
2
Cytokinetics
CYTK
$4.23B
| $123M | 5.79% | 1,757,192 | – | – |
|
3
Merck
MRK
$210B
| $78.7M | 3.7% | 596,261 | – | – |
|
4
AbbVie
ABBV
$372B
| $73.5M | 3.46% | 403,861 -3,152 | -0.8% | -$574K |
|
5
Edwards Lifesciences
EW
$47.8B
| $70.7M | 3.33% | 740,260 | – | – |
|
6
Vertex Pharmaceuticals
VRTX
$100B
| $62.2M | 2.93% | 148,852 | – | – |
|
7
Tenet Healthcare
THC
$16.3B
| $62M | 2.91% | 589,409 | – | – |
|
8
McKesson
MCK
$85.4B
| $52.3M | 2.46% | 97,498 | – | – |
|
9
Centene
CNC
$14.3B
| $47M | 2.21% | 598,513 +40,762 | +7% | +$3.2M |
|
|
10
Intuitive Surgical
ISRG
$170B
| $44.3M | 2.08% | 111,037 +86,730 | +357% | +$34.6M |
|
11
Humana
HUM
$36.5B
| $43.5M | 2.04% | 125,340 | – | – |
|
12
Becton Dickinson
BDX
$55.3B
| $42.5M | 2% | 171,552 -28,489 | -14% | -$7.05M |
|
13
HCA Healthcare
HCA
$94.5B
| $41.6M | 1.96% | 124,840 | – | – |
|
14
Legend Biotech
LEGN
$6.41B
| $41.2M | 1.94% | 734,293 +55,217 | +8% | +$3.1M |
|
|
15
Zimmer Biomet
ZBH
$21B
| $39.6M | 1.86% | 300,351 +187,695 | +167% | +$24.8M |
|
16
Universal Health Services
UHS
$11.6B
| $39M | 1.84% | 213,983 +11,691 | +6% | +$2.13M |
|
17
Icon
ICLR
$13.8B
| $38.9M | 1.83% | 115,726 +13,914 | +14% | +$4.67M |
|
18
Axsome Therapeutics
AXSM
$6.05B
| $37.3M | 1.75% | 467,427 | – | – |
|
19
Penumbra
PEN
$10.6B
| $34.8M | 1.63% | 155,786 | – | – |
|
20
Avantor
AVTR
$9.18B
| $34.3M | 1.61% | 1,343,309 +666,571 | +98% | +$17M |
|
21
argenx
ARGX
$43.6B
| $34.2M | 1.61% | 86,832 | – | – |
|
22
Thermo Fisher Scientific
TMO
$186B
| $33.7M | 1.59% | 58,038 +6,710 | +13% | +$3.9M |
|
23
Caribou Biosciences
CRBU
$174M
| $33.3M | 1.57% | 6,483,270 +2,506 | +0% | +$12.9K |
|
24
Danaher
DHR
$147B
| $31.3M | 1.47% | 125,515 | – | – |
|
25
Praxis Precision Medicines
PRAX
$958M
| $29.1M | 1.37% | 477,605 -178,943 | -27% | -$10.9M |
|